Gene · 84909
Papers4,394
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,394
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics of Premature Myocardial Infarction Among Women With Prior Adverse Pregnancy Outcomes. | JACC Adv | 2023 | 37694271 | PubTator, text mining | PubMed |
| Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies. | Mol Cancer | 2023 | 37679783 | PubTator, text mining | PubMed |
| Structure-Based Optimization of Covalent, Small-Molecule Stabilizers of the 14-3-3σ/ERα Protein-Protein Interaction from Nonselective Fragments. | J Am Chem Soc | 2023 | 37676236 | PubTator, text mining | PubMed |
| Evidence for increased DNA damage repair in the postmortem brain of the high stress-response group of schizophrenia. | Front Psychiatry | 2023 | 37674553 | PubTator, text mining | PubMed |
| Amyloid-β exposed astrocytes induce iron transport from endothelial cells at the blood-brain barrier by altering the ratio of apo- and holo-transferrin. | J Neurochem | 2023 | 37667496 | PubTator, text mining | PubMed |
| Methods for automating the analysis of live-cell single-molecule FRET data. | Front Cell Dev Biol | 2023 | 37655158 | PubTator, text mining | PubMed |
| Identifying structural and dynamic changes during the Biliverdin Reductase B catalytic cycle. | Front Mol Biosci | 2023 | 37645217 | PubTator, text mining | PubMed |
| 3DDPDs: describing protein dynamics for proteochemometric bioactivity prediction. A case for (mutant) G protein-coupled receptors. | J Cheminform | 2023 | 37641107 | PubTator, text mining | PubMed |
| Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir. | ACS Cent Sci | 2023 | 37637734 | PubTator, text mining | PubMed |
| Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. | Front Endocrinol (Lausanne) | 2023 | 37635956 | PubTator, text mining | PubMed |
| HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus. | J Clin Med | 2023 | 37629447 | PubTator, text mining | PubMed |
| Aberrant HPO Axis Alterations and Autoimmune Abnormalities in PCOS Patients with DOR: A Retrospective Analysis. | J Clin Med | 2023 | 37629254 | PubTator, text mining | PubMed |
| RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. | Nat Med | 2023 | 37626170 | PubTator, text mining | PubMed |
| Structural basis of telomeric nucleosome recognition by shelterin factor TRF1. | Sci Adv | 2023 | 37624885 | PubTator, text mining | PubMed |
| Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals. | Front Pharmacol | 2023 | 37614313 | PubTator, text mining | PubMed |
| Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition. | Proc Natl Acad Sci U S A | 2023 | 37603740 | PubTator, text mining | PubMed |
| Design, optimization, production and activity testing of recombinant immunotoxins expressed in plants and plant cells for the treatment of monocytic leukemia. | Bioengineered | 2023 | 37598369 | PubTator, text mining | PubMed |
| Psychosocial effects of adverse pregnancy outcomes and their influence on reporting pregnancy loss during surveys and surveillance: narratives from Uganda. | BMC Public Health | 2023 | 37596665 | PubTator, text mining | PubMed |
| Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study. | Pharmacol Rep | 2023 | 37587394 | PubTator, text mining | PubMed |
| Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis. | PLoS One | 2023 | 37585409 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84909/papers?page=19